CHEPLAPHARM ARZNEIMITTEL GMBH
502074-9890ActiveGlobal platform acquiring and developing established specialty pharmaceutical brands.
Overview
- 0
- Employees
- 100–500M SEK
- Revenue
- 2014
- Founded
Key Decision Makers
Fabian Franke
Head of Investor Relations
Fabian Kunick
Senior Director Treasury & Investor Relations
Pierre Lüders
Head of Compliance, Export Control & Data Protection
Artem Gevorkyan
Senior Vice President Corporate Business Development
+14 more contacts in Funnelfeedr
Description
CHEPLAPHARM Arzneimittel GmbH is a globally active company headquartered in Germany, dedicated to building a sustainable platform for Specialty Pharma. Their core business involves investing in and carefully developing long-established, trusted branded pharmaceutical products acquired from research-...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- Utländsk juridisk person
- VAT Number
- SE502074989001
Decision Makers
18 contacts in FunnelfeedrFabian Franke
Head of Investor Relations
Fabian Kunick
Senior Director Treasury & Investor Relations
Pierre Lüders
Head of Compliance, Export Control & Data Protection
Artem Gevorkyan
Senior Vice President Corporate Business Development
Sebastian Braun
Chief Executive Officer
Sandra Schröder
Vice President Scientific
Caroline Jacquin
Managing Director France
Keyarasch Parssanedjad
Chief Financial Officer
Klaus Köhl
Chief Operating Officer
Tamás Szóga
Vice President Commercial
Edeltraud M. Lafer
Co-Chief Executive Officer
Dr. Markus Peterseim
Chief Technology Officer
Urška Škof Bušs
Vice President Global Integrations & Separations
Dr. Kia Parssanedjad
Chief Financial Officer
Karl "Charly" Lang
Vice President Supply Chain Logistics
Bianca Y. Juha
Chief Scientific Officer
Stephanie Lemke
Senior Investor Relations Manager
Other Contacts
Anna Rautenberg
Senior Specialist Compliance
Similar Companies
20 similar companies in FunnelfeedrINFECTOPHARM ARZNEIMITTEL UND CONSILIUM GMBH
0 employeesFamily-owned German pharmaceutical company specializing in innovative medicines.
Immedica Pharma AB
50–99 employeesCommercializing rare disease medicines globally through strategic partnerships.
Santhera Pharmaceuticals (Sweden) AB
1–4 employeesSwiss specialty pharma developing treatments for rare neuromuscular diseases.
Immedica Bidco AB
1–4 employeesCommercializing rare disease medicines globally through strategic partnerships.
INFECTOPHARM ARZEIMITTEL UND CONSILIUM GMBH
Family-owned firm developing innovative, patient-centered established medications.
Browse More
CHEPLAPHARM ARZNEIMITTEL GMBH Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo